VEGFA and neoplasm: This lipid nanovesicle (ALN-VSP) encapsulated siRNAs targeting vascular endothelial growth factor (VEGF) and kinesin spindle protein (KSP) to treat patients with liver metastases.38 Tumor regression was achieved in nearly 50% of the patients in the trial.